CureVac NV (Germany) Analysis
| 5CV Stock | EUR 2.77 0.01 0.36% |
CureVac NV is fairly valued with Real Value of 2.69 and Hype Value of 2.77. The main objective of CureVac NV stock analysis is to determine its intrinsic value, which is an estimate of what CureVac NV is worth, separate from its market price. There are two main types of CureVac NV's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect CureVac NV's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of CureVac NV's stock to identify patterns and trends that may indicate its future price movements.
The CureVac NV stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CureVac NV's ongoing operational relationships across important fundamental and technical indicators.
CureVac |
CureVac Stock Analysis Notes
About 46.0% of the company shares are owned by insiders or employees . The book value of CureVac NV was presently reported as 3.29. The company recorded a loss per share of 0.63. CureVac NV had not issued any dividends in recent years. CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. CUREVAC N operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 455 people. For more info on CureVac NV please contact LLM LLM at 49 7071 9883 0 or go to https://www.curevac.com.CureVac NV Investment Alerts
| CureVac NV had very high historical volatility over the last 90 days | |
| The company reported the revenue of 102.99 M. Net Loss for the year was (411.72 M) with loss before overhead, payroll, taxes, and interest of (135.09 M). | |
| CureVac NV has accumulated about 1.33 B in cash with (733.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 46.0% of the company shares are owned by insiders or employees |
CureVac Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.85 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CureVac NV's market, we take the total number of its shares issued and multiply it by CureVac NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.CureVac Profitablity
CureVac NV's profitability indicators refer to fundamental financial ratios that showcase CureVac NV's ability to generate income relative to its revenue or operating costs. If, let's say, CureVac NV is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, CureVac NV's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of CureVac NV's profitability requires more research than a typical breakdown of CureVac NV's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (1.26) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (7.27) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.27. Technical Drivers
As of the 21st of March, CureVac NV shows the Mean Deviation of 3.11, risk adjusted performance of 0.0017, and Standard Deviation of 4.56. CureVac NV technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CureVac NV treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if CureVac NV is priced correctly, providing market reflects its regular price of 2.77 per share.CureVac NV Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CureVac NV middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CureVac NV. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
CureVac NV Outstanding Bonds
CureVac NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CureVac NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CureVac bonds can be classified according to their maturity, which is the date when CureVac NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
CureVac NV Predictive Daily Indicators
CureVac NV intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CureVac NV stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CureVac NV Forecast Models
CureVac NV's time-series forecasting models are one of many CureVac NV's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CureVac NV's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About CureVac Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how CureVac NV prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CureVac shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CureVac NV. By using and applying CureVac Stock analysis, traders can create a robust methodology for identifying CureVac entry and exit points for their positions.
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid . The company was founded in 2000 and is headquartered in Tbingen, Germany. CUREVAC N operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 455 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding CureVac NV to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |